# the Use of Tranexamic Acid to Prevent the Bleeding in Bariatric Surgery

> **NCT07187258** · PHASE4 · COMPLETED · sponsor: **Cairo University** · enrollment: 132 (actual)

## Conditions studied

- Haemorrhage
- Bariatric Surgery Candidate

## Interventions

- **DRUG:** tranexamic acid (1 g diluted in 100 mL of 0.9% saline
- **DRUG:** placebo (100 mL of 0.9% saline).

## Key facts

- **NCT ID:** NCT07187258
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-01
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-07-01
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07187258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07187258, "the Use of Tranexamic Acid to Prevent the Bleeding in Bariatric Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07187258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*